| Título: | Screening Mammography for Breast Cancer in Women Using Bi-RADS Scores |
| Autores: |
Tariq, MM; Institute of Allied Health Sciences, FMH-College of Medicine and Dentistry, Lahore. Pakistan Khubaib, S; Institute of Allied Health Sciences, FMH-College of Medicine and Dentistry, Lahore. Pakistan Imran, AB; Institute of Allied Health Sciences, FMH-College of Medicine and Dentistry, Lahore. Pakistan Ibrahim, M; School of Physiotherapy, Mayo Hospital KEMU/ GDS College, Lahore Pakistan |
| Fecha: | 2011-09-20 |
| Publicador: | Shahid Beheshti University of Medical Sciences |
| Fuente: |
Ver documento |
| Tipo: |
info:eu-repo/semantics/article info:eu-repo/semantics/publishedVersion |
| Tema: | Breast Neoplasm; Breast imaging; Mammography; Screening; BI-RADS |
| Descripción: | Background: Breast cancer is third order malignancy in women among other malignancies. Various studies showed that incidence of breast cancer can be lower down by early detection of breast cancer. Mammographic screening is considered more effective modality in detecting early stage breast cancer in women who are at elevated risk for breast cancer. The aim of this study is to report the results of mammographic screening of women based on the Breast Imaging Reporting and Data System (BI-RADS) for breast cancer. Methods: Five hundred four women aged >40 years with no history of breast cancer, no complaints of breast symptoms during any self or clinical examination were underwent breast cancer screening using MAMMOMATE 1000 (Siemens). Descriptive analysis is performed for imaging finding and risk factors. Results: The mean age of 504 women was 51±9.18 years. No family history of breast cancer was present in 418 women (82.9%: 95% CI, 79.4-86.1%). No cancer (negative & benign) was found in 469 women (93.1%: 95% CI, 90.47-95.12%) with R1/R2 scores. For breast imaging scores, 71.62% of all women were R1, 21.42% were R2, 2.38% were R3 while 4.58% were R4 and above. No association (P>0.05) was found between BI-RADS imaging scores and risk factors. Conclusion: In spite of low prevalence of breast cancer in our participants, still there is a need to educate the women at country level about the risk of breast cancer and significance of screening as a tool of early detection of breast cancer. Keywords: Breast Neoplasm; Breast imaging; Mammography; Screening; BI-RADS References1. Ferlay J, Bray F, Pisani P, Parkin DM. GLOBOCAN (2002). Cancer incidence, Mortality and prevalence Worldwide. IARC Cancer base No. 5, Version 2.0. IARC Press. Lyon. 2004.2. Sohail S, Alam SN. Breast cancer in Pakistan - awareness and early detectionJ Coll Physicians Surg Pak Dec 2007; 17(12):711-2.3. http//:www.medicinenet.com/ breast_cancer/article.htm4. http://www.imaginis.com/breast-health/what-are-the-risk-factors-for-breast-cancer5. Early Breast Cancer Trialists' Collaborative Group. Effects of chemotherapy and hormonal therapy for early breast cancer on recurrence and 15-year survival. an overview of the randomised trials. Lancet 2005, 365:1687–1717.6. Early Breast Cancer Trialists' Collaborative Group. Multi-agent chemotherapy for early breast cancer.Cochrane Database Syst Rev 2002:CD000487.7. Vervoort MM, Draisma G, Fracheboud J, Poll Franse LV van de, de Koning HJ. Trends in the usage of adjuvant systemic therapy for breast cancer in the Netherlands and its effect on mortality.Br J Cancer 2004; 91:242–7.8. Kamangar F, Dores GM, Anderson WF. Patterns of cancer incidence, mortality, and prevalence across five continents. defining priorities to reduce cancer disparities in different geographic regions of the world. J Clin Oncol 2006, 24:2137–50.9. Cancer Trends Progress Report-2007 update, [http://progressreport.cancer.gov/popups/d2b.html].10. Nystrom L, Andersson L, Bjurstam N, Frisell J, Nordenskjold B, Rutqvist LE. Long term effects of mammography screening: updated overview of the Swedish randomized trials. Lancet 2002, 359:909–19.11. Olsen AH, Njor SH, Vejborg I, Schwartz W, Dalgaard P, Jensen MB, Tanque UB, Blichert-Toft M, Rank F, Mouridsen H, Lynge E. Breast cancer mortality in Copenhagen after introduction of mammography screening: cohort study.BMJ 2005, 330:220.12. Tabar L, Yen MF, Vitak B, Chen HH, Smith RA, Duffy SW. Mammography service screening and mortality in breast cancer patients: 20-year follow-up before and after introduction of screening.Lancet 2003, 361:1405–10.13. Berry DA, Corin KA, Plevritis SK, Fryback DG, Clarke L, Zelen M, et al. Effect of screening and adjuvant therapy on mortality from breast cancer. N Engl J Med 2005, 353:1784–92.14. Tabar L, Fagerberg CJ, Gad A, Baldetorp L, Holmberg LH, Grφntoft O, et al. Reduction in breast cancer mortality by mass screening with mammography: First results of a randomized trial in two Swedish countries. Lancet 1985; 1:829-32.15. Collette H, Rombach J, Day NE, de Waard F. Evaluation of screening for breast cancer in a non-randomized study by means of a case-control study. Lancet 1984; 1:1224-6. 16. Verbeek AL, Hendriks JH, Holland R, Mravunac M, Sturmans F. Mammographic screening and breast cancer mortality: Age-specific effects in Nijmegen Project, 1975-82. Lancet 1985; 1:865-6.17. US Preventive Services Task Force. The guide to clinical preventive services, 2nd ed. Alexandria, VA: International Medical Publishing, 1996. 18. Jazieh AR, Soora I. Mammography utilization pattern throughout the State of Arkansas: A challenge for the future. J Community Health 2001; 26:249-55. 19. O′Malley MS, Earp JA, Hawley ST, Schell MJ, Mathews HF, Mitchell J. The association of race/ethnicity, socioeconomic status and physician recommendation for mammography: Who gets the message about breast cancer screening? Am J Public Health 2001; 91:49-54.20. Maqsood B, Zeeshan MM, Rehman F, Aslam F, Zafar A, Syed B, et al. Breast Cancer screening practices and awareness in women admitted to a Tertiary Care Hospital of Lahore, Pakistan. J Pak Med Assoc Jun 2009; 59(6):418-21.21. Bhurgri H, Gowani SA, Itrat A, Samani S, Zuberi A. Awareness of cancer risk factors among patients and attendants presenting to a Tertiary Care Hospital in Karachi, Pakistan. J Pak Med Assoc Oct 2008; 58(10):584-9.22. World care clinical; Weekly Guide to Harmonizing Clinical Trial Imaging: Volume 1, Number 4, October 17, 2007, http://www.wcclinical.com/.23. Susan M. Astley. (Eds.): IWDM 2006, LNCS 4046, pp. 407–415, 2006.24. American College of Radiology. The ACR breast imaging reporting and data system (BI-RADS) [web source]. November 11, 2003. Available from: http:// www. Acr. org/departments/stand_accred/birads/contents.html. Accessed February, 27, 2004.25. Eberl MM, Fox CH, Edge SB, Carter CA, Mahoney MC. BI-RADS classification for management of abnormal mammograms. J Am Board Fam Med 2006; 19:161-4.26. Abulkhair OA, Al Tahan FM, Young SE, Musaad SM, Jazieh AM. The first national public breast cancer screening program in Saudi Arabia. Ann Saudi Med 2010; 30:350-7.27. Wijdan Akram. Screening of Breast Mass in Iraqi Females: Al-Kindy Hospital Breast Clinic. American Journal of Infectious Diseases 2009; 5 (4): 320-3.28. Roseman DL, Straus AK, Shorey W. A positive family history of breast cancer. Does it affect diminish with age? Arch Intern Med. 1990 Jan; 150(1):191-4.29. http://www.cancer.org/Cancer/BreastCancer/DetailedGuide/breast-cancer-risk-factors.30. James T B, Margaret M K, Kevin M G. Occupation and breast cancer: a Canadian Case-control study. Ann. N. Y. Acad. Sci. 2006; 1076: 765-77.31. The World Health Report, 1997 on Life expectancy of world.32. Asim Jaffary, Farah Mansuri, Shabnam Shamin, Shahzad Shamim. Knowledge attitudes and practices regarding breast cancer screening in women of various social strata. J Surg Pak Dec 2005; 10(4):44-7.33. Brett J, Bankhead C, Henderson B, Watson E, Austoker J. The psychological impact of mammographic screening. A systematic review. Psychooncology. 2005 Nov; 14(11):917-38.34. KelseyJL, Horn-Ross PL. Breast cancer: Magnitude of the problem and descriptive epidemiology. Epidemiol. Rev., 15: 7-16. 1993. http:// www. ncbi. nlm. nih. gov/ pubmed/8405214. |
| Idioma: | Inglés |
1 Health and Education - 2 por Akbari, Mohammad Esmaeil | 6 Effectiveness of Mindfulness-Based Cognitive Therapy on Reduction of Depression and Anxiety Symptoms in Mothers of Children With Cancer por Mehranfar, Mojtaba; Dept. of Counselling, University of Social Welfare and Rehabilitation Sciences, Tehran, Iran,Younesi, Jalal; Dept. of Counselling, University of Social Welfare and Rehabilitation Sciences, Tehran, Iran,Banihashem, Abdollah; Dept. of Internal Medicine and Paediatrics, University of
Medical Sciences, Mashhad, Iran |
2 The Study of DNA Methylation of bax Gene Promoter in Breast and Colorectal Carcinoma Cell Lines por Alipour, Mohsen; Dept. of Cell and Molecular Biology, School of Biology, College of Science, University of Tehran, Tehran, Iran,Zargar, Seyed Jalal; Dept. of Cell and Molecular Biology, School of Biology, College of Science, University of Tehran, Tehran, Iran,Safarian, Shahrokh; Dept. of Cell and Molecular Biology, School of Biology, College of Science, University of Tehran, Tehran, Iran,Fouladdel, Shamile; Dept. of Pharmacology and Toxicology, Faculty of Pharmacy, Tehran University of Medical Sciences, Tehran, Iran,Azizi, Ebrahim; Dept. of Pharmacology and Toxicology, Faculty of Pharmacy, Tehran University of Medical Sciences, Tehran, Iran
Biotechnology Research Center, Tehran University of Medical Sciences, Tehran, Iran,Jafargholizadeh, Naser; Dept. of Cell & Molecular Biology, School of Biology, College of Science, University of Tehran, Tehran, Iran | 7 Prevention and Management of Mucositis in Patients With Cancer: a Review Article por [wlia, ّatemeh; Dept. of Oral Medicine, Yazd Shahid Sadoughi University of Medical Sciences, Yazd, Iran,«azemeini, ُeidkazem; Burn hospital, Yazd Shahid Sadoughi University of Medical Sciences, Yazd, Iran,gholami, neda; Dept. of Oral Medicine, Yazd Shahid Sadoughi University of Medical Sciences, Yazd, Iran |
3 Cancer Prevention; Cancer Risk Management por Akbari, Mohammad Esmaeil | 8 Psychosocial Care for Breast Cancer: Physicians' Perspective por Kaviani, Ahmad; Department of surgery, Tehran University of Medical Sciences, Tehran, Iran,Mehrdad, N; Iranian Center for Breast Cancer (ICBC), Academic Center for Education, Culture and Research (ACECR), Tehran, Iran,Yunesian, M; school of Public Health , Environmental Research Center, Tehran University of Medical Sciences, Tehran, Iran,Shakiba, B; Students’ Scientific Research Center, Tehran University of Medical Sciences, Tehran, Iran,Ebrahimi, M; Iranian Center for Breast Cancer (ICBC), Academic Center for Education, Culture and Research (ACECR), Tehran, Iran,Majidzadeh, K; Iranian Center for Breast Cancer (ICBC), Academic Center for Education, Culture and Research (ACECR), Tehran, Iran,Akbari, ME; Cancer Research Center, Shahid Beheshti University of Medical Sciences, Tehran, Iran |
4 Euthanasia in Cancer Patients, Islamic Point of View por Mousavi, SM; Cancer Research Center, Shahid Beheshti University of Medical Sciences, Tehran, Iran,Akbari, A; Cancer Research Center, Shahid Beheshti University of Medical Sciences, Tehran, Iran,Akbari, ME; Cancer Research Center, Shahid Beheshti University of Medical Sciences, Tehran, Iran,Najd Sepas, H; Cancer Research Center, Shahid Beheshti University of Medical Sciences, Tehran, Iran | 9 Cell Survival Entropy and Cellular Resistance Activation Dose: Effect of Calprotectin on Gastric Adenocarcinoma Cell Line por Rezaei-Tavirani, Mostafa,Rahmati-Roodsari, Mohammad,Mirzaie, Mehdi,Amini Geram, Pooneh,Sobhi, Sara |
5 Evaluation of Prognostic Factors In Patients with Metastatic Breast Cancer por Saeidi Saedi, H,Seilanian Toosi, M,Mirsadraei, M,Roodbari, S | 10 Antiphospholipid Antibodies in Neoplastic Patients por Mortazavizadeh, MR,Sadeghmanesh, R |